Barriers for conducting clinical trials in developing countries- a systematic review

Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing coun...

Full description

Bibliographic Details
Main Authors: Chalachew Alemayehu, Geoffrey Mitchell, Jane Nikles
Format: Article
Language:English
Published: BMC 2018-03-01
Series:International Journal for Equity in Health
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12939-018-0748-6
id doaj-0a41dcc3afca4bbd9f83b73f5f738285
record_format Article
spelling doaj-0a41dcc3afca4bbd9f83b73f5f7382852020-11-24T21:23:14ZengBMCInternational Journal for Equity in Health1475-92762018-03-0117111110.1186/s12939-018-0748-6Barriers for conducting clinical trials in developing countries- a systematic reviewChalachew Alemayehu0Geoffrey Mitchell1Jane Nikles2Faculty of Medicine University of QueenslandFaculty of Medicine University of QueenslandThe University of Queensland Centre for Clinical Reseaerch (UQCCR)Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing countries. However, gross under-representation in global clinical trial platforms contributes to sustained health inequity in these countries. We reviewed the literature on barriers facing clinical researchers in developing countries for conducting clinical trials in their countries. Methods Literature indexed in PubMed, Embase, CINAHL and Web of Science, WHO Global Health Library were searched. Grey literature was also searched. Search key words included barriers, challenges, clinical trials and developing countries. Articles within the scope of this review were appraised by two reviewers. Results Ten studies, which are reported in 15 papers, were included in this review. Following critical review we identified five unifying themes for barriers. Barriers for conducting clinical trials included lack of financial and human capacity, ethical and regulatory system obstacles, lack of research environment, operational barriers and competing demands. Conclusion and recommendation There were substantial barriers at system, organization and individual level. We propose that to address this problem, instituting a system for wider implementation of local investigator-initiated trials is warranted. These trials are more applicable to local populations because they build on local healthcare knowledge. They are more demand-led, influence policy and responsive to a country’s needs because they are driven by a local or national agenda.http://link.springer.com/article/10.1186/s12939-018-0748-6BarriersClinical trialsDeveloping countries
collection DOAJ
language English
format Article
sources DOAJ
author Chalachew Alemayehu
Geoffrey Mitchell
Jane Nikles
spellingShingle Chalachew Alemayehu
Geoffrey Mitchell
Jane Nikles
Barriers for conducting clinical trials in developing countries- a systematic review
International Journal for Equity in Health
Barriers
Clinical trials
Developing countries
author_facet Chalachew Alemayehu
Geoffrey Mitchell
Jane Nikles
author_sort Chalachew Alemayehu
title Barriers for conducting clinical trials in developing countries- a systematic review
title_short Barriers for conducting clinical trials in developing countries- a systematic review
title_full Barriers for conducting clinical trials in developing countries- a systematic review
title_fullStr Barriers for conducting clinical trials in developing countries- a systematic review
title_full_unstemmed Barriers for conducting clinical trials in developing countries- a systematic review
title_sort barriers for conducting clinical trials in developing countries- a systematic review
publisher BMC
series International Journal for Equity in Health
issn 1475-9276
publishDate 2018-03-01
description Abstract Background Clinical trials for identification of efficient and effective new diagnostic and treatment modalities are needed to address disproportionately high burden of communicable (e.g., HIV/AIDS, tuberculosis, and malaria) and non-communicable diseases (e.g., diabetes) in developing countries. However, gross under-representation in global clinical trial platforms contributes to sustained health inequity in these countries. We reviewed the literature on barriers facing clinical researchers in developing countries for conducting clinical trials in their countries. Methods Literature indexed in PubMed, Embase, CINAHL and Web of Science, WHO Global Health Library were searched. Grey literature was also searched. Search key words included barriers, challenges, clinical trials and developing countries. Articles within the scope of this review were appraised by two reviewers. Results Ten studies, which are reported in 15 papers, were included in this review. Following critical review we identified five unifying themes for barriers. Barriers for conducting clinical trials included lack of financial and human capacity, ethical and regulatory system obstacles, lack of research environment, operational barriers and competing demands. Conclusion and recommendation There were substantial barriers at system, organization and individual level. We propose that to address this problem, instituting a system for wider implementation of local investigator-initiated trials is warranted. These trials are more applicable to local populations because they build on local healthcare knowledge. They are more demand-led, influence policy and responsive to a country’s needs because they are driven by a local or national agenda.
topic Barriers
Clinical trials
Developing countries
url http://link.springer.com/article/10.1186/s12939-018-0748-6
work_keys_str_mv AT chalachewalemayehu barriersforconductingclinicaltrialsindevelopingcountriesasystematicreview
AT geoffreymitchell barriersforconductingclinicaltrialsindevelopingcountriesasystematicreview
AT janenikles barriersforconductingclinicaltrialsindevelopingcountriesasystematicreview
_version_ 1725992803280879616